Aurora Cannabis Inc. (TSX:ACB)
Canada · Delayed Price · Currency is CAD 4.040
-0.010 (-0.25%)
Jun 29, 2026, 10:59 AM EST
Aurora Cannabis Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Jun '22 Jun 30, 2022 |
| 320.59 | 288.91 | 269.64 | 223.8 | 221.34 | |
Revenue Growth (YoY) | 10.97% | 7.15% | 20.48% | 1.11% | -9.75% |
Cost of Revenue | 183.94 | 107.96 | 137.91 | 209.02 | 200.11 |
Gross Profit | 136.65 | 180.95 | 131.73 | 14.78 | 21.23 |
Selling, General & Admin | 168.18 | 150.93 | 143.24 | 156.24 | 162.34 |
Research & Development | 4.02 | 3.68 | 3.57 | 5.77 | 10.39 |
Operating Expenses | 183.31 | 170.52 | 171.5 | 202.37 | 235.09 |
Operating Income | -46.66 | 10.43 | -39.78 | -187.59 | -213.86 |
Interest Expense | -1.81 | -2.52 | -13.8 | -44.46 | -71.81 |
Interest & Investment Income | 5.85 | 10.31 | 12.82 | 14.91 | 4.51 |
Earnings From Equity Investments | - | - | - | 0.05 | -0.29 |
Currency Exchange Gain (Loss) | 1.34 | 11.66 | -0.42 | 8.87 | -0.3 |
Other Non Operating Income (Expenses) | 0.72 | 2.1 | 14.77 | 14.93 | 55.61 |
EBT Excluding Unusual Items | -40.56 | 31.99 | -26.4 | -193.28 | -226.15 |
Merger & Restructuring Charges | - | - | -6.83 | -17.43 | -19.62 |
Impairment of Goodwill | - | - | - | - | -914.28 |
Gain (Loss) on Sale of Investments | - | - | - | -4.59 | -5.48 |
Gain (Loss) on Sale of Assets | - | - | 1.16 | 3.12 | 0.37 |
Asset Writedown | -15.96 | -0.7 | -36.9 | -570.82 | -544.04 |
Legal Settlements | - | - | -1.72 | -3.58 | -1.23 |
Other Unusual Items | - | - | 13.06 | -30.21 | -9.7 |
Pretax Income | -56.52 | 31.3 | -57.64 | -816.8 | -1,720 |
Income Tax Expense | 2.1 | 4.25 | -0.55 | -16.55 | -2.14 |
Earnings From Continuing Operations | -58.62 | 27.05 | -57.08 | -800.25 | -1,718 |
Earnings From Discontinued Operations | -77.35 | -25.46 | -12.24 | -23.67 | - |
Net Income to Company | -135.96 | 1.59 | -69.33 | -823.91 | -1,718 |
Minority Interest in Earnings | - | - | 3.74 | 7.29 | 0.36 |
Net Income | -135.96 | 1.59 | -65.58 | -816.63 | -1,718 |
Net Income to Common | -135.96 | 1.59 | -65.58 | -816.63 | -1,718 |
Shares Outstanding (Basic) | 57 | 55 | 43 | 30 | 21 |
Shares Outstanding (Diluted) | 57 | 56 | 43 | 30 | 21 |
Shares Change (YoY) | 1.96% | 28.69% | 42.03% | 41.60% | 27.08% |
EPS (Basic) | -2.40 | 0.03 | -1.52 | -26.84 | -79.92 |
EPS (Diluted) | -2.40 | 0.03 | -1.52 | -26.84 | -79.92 |
Free Cash Flow | -36.06 | 0.95 | -85.34 | -162.61 | -142.48 |
Free Cash Flow Per Share | -0.64 | 0.02 | -1.97 | -5.34 | -6.63 |
Gross Margin | 42.62% | 62.63% | 48.85% | 6.61% | 9.59% |
Operating Margin | -14.56% | 3.61% | -14.75% | -83.82% | -96.62% |
Profit Margin | -42.41% | 0.55% | -24.32% | -364.88% | -776.01% |
Free Cash Flow Margin | -11.25% | 0.33% | -31.65% | -72.66% | -64.37% |
EBITDA | -32.96 | 23.04 | -7 | -135 | -127.04 |
EBITDA Margin | -10.28% | 7.97% | -2.60% | -60.32% | -57.40% |
D&A For EBITDA | 13.7 | 12.6 | 32.78 | 52.59 | 86.82 |
EBIT | -46.66 | 10.43 | -39.78 | -187.59 | -213.86 |
EBIT Margin | -14.56% | 3.61% | -14.75% | -83.82% | -96.62% |
Effective Tax Rate | - | 13.56% | - | - | - |
Revenue as Reported | 320.59 | 288.91 | 269.64 | 223.8 | 221.34 |